Summary
This was a payment week dressed up as a leadership week. CMS announced CJR-X, a nationwide mandatory joint replacement bundle starting January 1, 2028, covering hip, knee, and ankle plus 90 days of recovery. In the same seven days, the proposed CY2027 Physician Fee Schedule put work RVU cuts of 16.6% on TKA, 19.6% on THA, and 19% on TSA on the table.
Stryker announced that Kevin Lobo moves to Executive Chair and Spencer Stiles, the former Orthopaedics group president, becomes CEO on January 1, 2027. Centinel Spine filed its public S-1 for a NYSE IPO under CNTL, reported at up to $100M, on H1 revenue of $85.2M (up 42%) and $10.2M of net income.
The UK National Joint Registry looked at more than 1.3 million hips and knees and found no early revision or complication benefit for robotic-assisted surgery. Reimbursement kept doing the heavy lifting in spine: icotec’s CMORE CT picked up NTAP, Carlsmed’s aprevo picked up higher payment under the new FY2027 MS-DRGs 523–525, and NASS widened its rhBMP-2 coverage recommendations for high nonunion-risk fusions.
Sector
Notable Move
Key Strategic Implication
Joint replacement payment
CMS CJR-X mandatory nationwide bundle (hip, kn...
